Abstract
IDF2022-0745 Empagliflozin-based quadruple therapy versus insulin glargine-based therapy in type 2 diabetes: 3-year follow-up data
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.diabres.2023.110327
Publication Date: Mar 1, 2023 |
IDF2022-0745 Empagliflozin-based quadruple therapy versus insulin glargine-based therapy in type 2 diabetes: 3-year follow-up data
Join us for a 30 min session where you can share your feedback and ask us any queries you have